Hantz Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$623K Buy
3,293
+973
+42% +$170K 0.01% 587
2025
Q4
$394K Buy
2,320
+983
+74% +$151K 0.01% 659
2025
Q3
$176K Buy
1,337
+977
+271% +$117K ﹤0.01% 775
2025
Q2
$38K Buy
360
+297
+471% +$32.3K ﹤0.01% 1049
2025
Q1
$8K Buy
63
+48
+320% +$6.26K ﹤0.01% 1026
2024
Q4
$2K Hold
15
﹤0.01% 986
2024
Q3
$2K Buy
15
+6
+67% +$657 ﹤0.01% 963
2024
Q2
$1K Hold
9
﹤0.01% 1007
2024
Q1
$1K Hold
9
﹤0.01% 1131
2023
Q4
$1K Hold
9
﹤0.01% 1078
2023
Q3
$1K Sell
9
-33
-79% -$4.4K ﹤0.01% 1073
2023
Q2
$5K Hold
42
﹤0.01% 882
2023
Q1
$6K Hold
42
﹤0.01% 866
2022
Q4
$7K Buy
42
+33
+367% +$4.84K ﹤0.01% 809
2022
Q3
$1K Sell
9
-245
-96% -$37.3K ﹤0.01% 1020
2022
Q2
$40K Sell
254
-35
-12% -$5.39K ﹤0.01% 609
2022
Q1
$45K Buy
+289
New +$41.9K ﹤0.01% 619
2021
Q1
Sell
-13
Closed -$2K 715
2020
Q4
$2K Sell
13
-28
-68% -$4.17K ﹤0.01% 596
2020
Q3
$6K Sell
41
-59
-59% -$7.31K ﹤0.01% 512
2020
Q2
$11K Sell
100
-30,182
-100% -$3.34M ﹤0.01% 473
2020
Q1
$3.02M Buy
+30,282
New +$3.92M 0.21% 153

Other funds holding JAZZ

Hantz Financial Services's JAZZ Position: Q1 2026 in Review

Hantz Financial Services increased its Jazz Pharmaceuticals (JAZZ) stake by 42% in Q1 2026, buying an estimated $170K and bringing the position to 3,293 shares worth $623K. The position accounts for 0.01% of the portfolio, ranked #587.

Hantz Financial Services first reported a position in JAZZ in Q1 2020 and has held it in 21 quarters since. The position peaked at $3.02M in Q1 2020. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Hantz Financial Services held 3,293 shares of Jazz Pharmaceuticals worth $623K as of Q1 2026.
  • Hantz Financial Services bought 973 Jazz Pharmaceuticals shares in Q1 2026, an estimated $170K.
  • Jazz Pharmaceuticals made up 0.01% of Hantz Financial Services's portfolio in Q1 2026, its #587 holding.
  • Hantz Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 21 quarters since.
  • Hantz Financial Services's Jazz Pharmaceuticals position peaked at $3.02M in Q1 2020.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.